The ability of MSC to induce apoptosis of T cells was investigated, both in vitro and in vivo. The induction of PBMC apoptosis in vitro by human MSC was examined using an MSC/PBMC co-culture model. A known inducer of PBMC apoptosis, cisplatin, caused significant apoptosis of PBMC (Fig. 4a), whereas allogeneic human MSC did not (P < 0·0001) (Fig. 4a). However, the lack of apoptosis in vitro might not reflect GSK1120212 nmr the in vivo situation, therefore the NSG model was adapted to detect apoptotic cells. NSG mice were treated with PBS or PBMC, with or without MSCγ cell therapy on day 0. FLIVO (a reagent which detects active caspases of apoptotic cells

in vivo) was administered i.v. 12 days later and allowed to circulate for 1 h. After www.selleckchem.com/JAK.html 1 h, the lungs (Fig. 4b) and livers (Fig. 4c) were harvested and analysed for FLIVO/CD4 staining by two-colour flow cytometry. Although CD4+ T cells were detected, there was no increase in apoptotic CD4+ T cells following MSCγ therapy in either organ sampled on day 12 (Fig. 4b,c) or at other times prior to day 12 (days 1 or 5, data not shown). These data suggested that MSC did not induce detectable apoptosis of donor human CD4+ T cells in vivo or in vitro and that this was unlikely to be the mechanism involved in the beneficial effect mediated by MSC in this

model. An alternative hypothesis for the beneficial effect of MSC cell therapy was formulated around the induction of donor

T cell anergy. To examine this, an in vitro two-step proliferation assay was designed which would closely mimic in vivo circumstances. First, murine DC isolated from the bone marrow of BALB/c mice were used to mimic the murine (host) antigen-presenting cell. These were matured using polyIC as a stimulus and co-cultured with human CD4+ T cells for 5 days in the presence or absence of MSC. After 5 days, the proliferation of human CD4+ T cells was analysed. Human CD4+ T cells proliferated strongly when cultured with mature murine NADPH-cytochrome-c2 reductase DC (P < 0·0001); however, allogeneic human MSC significantly reduced this effect (P < 0·05) (Fig. 5a). These data showed that MSC were capable of inhibiting T cell proliferation in a xenogeneic setting, analogous to that found in the aGVHD NSG model. To examine if the reduction in T cell proliferation by MSC was due to the induction of T cell anergy, a two-stage assay was then performed. Human CD4+ T cells were co-cultured with mature murine DC and/or MSC for 5 days; human CD4+ T cells were re-isolated from cultures by magnetic bead isolation. Re-isolated CD4+ T cells were allowed to rest overnight then cultured for a second time with irradiated BALB/c DC stimulated with or without polyIC/IL-2. Following the second-stage co-culture, human CD4+ T cells proliferated in response to irradiated mature DC (Fig. 5b).